Evidence map›Paper›PMID 25463755›Full record

ArticleJournal of proteomics2015

SPECHT - single-stage phosphopeptide enrichment and stable-isotope chemical tagging: quantitative phosphoproteomics of insulin action in muscle.

Arminja N Kettenbach, Hiroyuki Sano, Susanna R Keller, Gustav E Lienhard, Scott A Gerber

Open access · greenAbstract read
In one paragraph

Article in Journal of proteomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Arminja N KettenbachDepartment of Biochemistry, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA; Norris Cotton Cancer Center, Lebanon, NH 03756, USA. Electronic address: arminja.n.kettenbach@dartmouth.edu.
Hiroyuki SanoDepartment of Biochemistry, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA.
Susanna R KellerDepartment of Medicine, Division of Endocrinology, University of Virginia, Charlottesville, VA 22903, USA.
Gustav E LienhardDepartment of Biochemistry, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA.
Scott A GerberDepartment of Biochemistry, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA; Norris Cotton Cancer Center, Lebanon, NH 03756, USA; Department of Genetics, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA. Electronic address: scott.a.gerber@dartmouth.edu.
Dartmouth College · USCotton (United States) · USUniversity of Virginia · US

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
PHOSPHOTYROSYL PROTEINS IN INSULIN RECEPTOR SIGNALINGR01DK042816 · NIDDK · DARTMOUTH COLLEGE · PI LIENHARD, GUSTAV E. · 1990 to 2008
$3.9M
Translational phosphoproteomics for lung cancerR01CA155260 · NCI · DARTMOUTH COLLEGE · PI GERBER, SCOTT A. · 2011 to 2015
$1.8M
Phosphoproteins in Insulin SignalingR56DK042816 · NIDDK · DARTMOUTH COLLEGE · PI LIENHARD, GUSTAV E. · 2011 to 2011
$316k
NCI NIH HHS CA15526NCI NIH HHS P30 CA023108NCI NIH HHS R01 CA155260NIDDK NIH HHS DK042816NIDDK NIH HHS R01 DK042816NIDDK NIH HHS R56 DK042816
6 · The paper itself

Abstract

The study of cellular signaling remains a significant challenge for translational and clinical research. In particular, robust and accurate methods for quantitative phosphoproteomics in tissues and tumors represent significant hurdles for such efforts. In the present work, we design, implement and validate a method for single-stage phosphopeptide enrichment and stable isotope chemical tagging, or SPECHT, that enables the use of iTRAQ, TMT and/or reductive dimethyl-labeling strategies to be applied to phosphoproteomics experiments performed on primary tissue. We develop and validate our approach using reductive dimethyl-labeling and HeLa cells in culture, and find these results indistinguishable from data generated from more traditional SILAC-labeled HeLa cells mixed at the cell level. We apply the SPECHT approach to the quantitative analysis of insulin signaling in a murine myotube cell line and muscle tissue, identify known as well as new phosphorylation events, and validate these phosphorylation sites using phospho-specific antibodies. Taken together, our work validates chemical tagging post-single-stage phosphoenrichment as a general strategy for studying cellular signaling in primary tissues. BIOLOGICAL SIGNIFICANCE: Through the use of a quantitatively reproducible, proteome-wide phosphopeptide enrichment strategy, we demonstrated the feasibility of post-phosphopeptide purification chemical labeling and tagging as an enabling approach for quantitative phosphoproteomics of primary tissues. Using reductive dimethyl labeling as a generalized chemical tagging strategy, we compared the performance of post-phosphopeptide purification chemical tagging to the well established community standard, SILAC, in insulin-stimulated tissue culture cells. We then extended our method to the analysis of low-dose insulin signaling in murine muscle tissue, and report on the analytical and biological significance of our results.

Indexed as

AnimalsCells, CulturedFemaleHeLa CellsHumansInsulinIsotope LabelingMiceMice, Inbred C57BLMuscle, SkeletalPhosphopeptidesPhosphoproteinsPhosphorylationProteomeProteomicsInsulinPhosphopeptidesPhosphoproteinsProteomeInsulin signalingPhosphoproteomicsQuantitative proteomicsTissue proteomics

Identifiers

PMID25463755
PMCPMC4289458
OpenAlexW1972688939

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.